By Luke Alley, PT, DPT | Health and Well-Being Coach

I once worked with a patient — I’ll call her Carol — who had just been discharged after a hospitalization for heart failure. She was sharp, engaged, asked good questions. Every time I went over the plan with her she nodded, repeated it back correctly, seemed genuinely bought in.

Six weeks later she was back. When I asked how the medications had been going, she paused. “Pretty good,” she said. Then, slowly, the real picture came out. She’d missed doses more days than she’d taken them. Not because she forgot. Because every time she looked at the pill organizer, she thought about how she felt before all of this started — fine, mostly — and wondered if she really needed all of it. Nobody had asked her that question before she left. So she answered it herself.

That was the moment I understood that the clinical plan and the patient’s lived experience of that plan are two completely different things. And the gap between them is where adherence goes to die.

Here is the number that should stop every provider mid-scroll: according to IHI Europe, adherence rates for on-market drug products range from just 7% to 87%, with an average sitting at 50%. That means, on average, half of your patients are not following through on the plan you built together.

This is not a patient failure. This is a system gap. And you are uniquely positioned to help close it.

This post is written for the providers, program directors, and clinicians who are tired of watching excellent clinical work get undone between appointments. Let’s look honestly at the patient factors affecting medication adherence — and what you can actually do about them.

It Is Not Laziness. It Is Complexity.

Before we go further, we need to reframe the narrative.

Non-adherence is not a character flaw. It’s a predictable, multi-variable outcome. When a patient stops taking their medication, something in their real life got in the way. Our job is to figure out what that something is — before it becomes a missed opportunity or a medical crisis.

Research identifies five core categories of patient factors affecting medication adherence:

• Psychological and motivational factors
• The quality of the healthcare provider relationship
• Health literacy and education level
• Side effects and treatment complexity
• Demographic and socioeconomic variables

These factors don’t work in isolation. A patient with low health literacy who also fears side effects and has minimal provider contact isn’t facing one barrier — they’re facing a compounding system of risk. Each layer makes the next one harder to overcome.

Let’s break each one down.

I worked with a client a few years ago who was managing Type 2 diabetes and had recently been diagnosed with early-stage hypertension. On paper, his medication regimen was straightforward. In practice, it was anything but.

When I started asking more questions, the layers came out one at a time. He didn’t fully understand why he needed two separate medications — his doctor had explained it, but the visit was short and he hadn’t wanted to ask again. He’d read something online about long-term kidney effects from one of the drugs and hadn’t told anyone because he didn’t want to seem difficult. And he was working two jobs, which meant his schedule was different every day. There was no consistent time to take his medication, so most days it just didn’t happen.

None of those barriers would have shown up in his chart. None of them would have surfaced in a standard follow-up call. They only came out because someone sat down with him and asked.

Once we identified all three layers — knowledge gap, fear, logistical inconsistency — we could actually address them. We worked with his care team to simplify the regimen, found a window in his schedule that was consistent across both jobs, and spent real time on the side effect concern until he felt confident enough to stop avoiding it. His adherence over the next three months was dramatically better.

The barriers were always there. They just needed someone to look for them.

Factor 1: The Motivation Gap — The Invisible Variable No One Is Measuring

Here is the most striking data point in the entire body of research on this topic.

Among patients with Type 2 diabetes, self-motivation was identified as the dominant factor influencing medication adherence. To put that in plain terms: motivated patients were dramatically more likely to stay consistent with their treatment plan than unmotivated patients. Not slightly more likely. Dramatically.

Among psychiatric patients, physicians identified two major barriers to adherence: patient skepticism toward conventional medical treatments, and a simple lack of time for patient discussion. On the flip side, the factors most strongly associated with adherence were patient motivation, trust in the physician, and the perceived positive effect of the medication.

Notice what is at the top of both lists. Motivation. Trust. Perceived value.

These are not clinical afterthoughts. These are the levers that move the needle.

If motivation is the dominant variable — and the research says it is — then motivational assessment must become a clinical standard, not an afterthought. You cannot address what you are not measuring. And right now, most clinical settings have no formal tool for measuring patient motivation at all.

That is the gap. And it is a big one.

If you want a structured starting point for assessing motivation in your patient population, the Patient Motivator Questionnaire was built specifically for this purpose. It helps providers identify the psychological and motivational barriers standing between their patients and consistent treatment adherence.

Factor 2: The Therapeutic Relationship — Your Most Underutilized Clinical Tool

Trust is not a soft metric. It is a clinical variable with measurable outcomes.

A trusting therapeutic relationship between provider and patient is one of the most consistently identified facilitators of medication adherence across the research literature. When patients trust their provider, they are more likely to ask questions, voice concerns, and stay consistent with their plan.

Here is what happens when that trust is absent.

In a study of asthma patients in Saudi Arabia, lack of medication support was independently associated with non-adherence — with an odds ratio of just 0.06. That means patients without adequate provider support were dramatically less likely to stay on course with their medication. Not a little less likely. Dramatically less likely.

Physicians themselves, when asked about the most effective intervention strategies, pointed to two things above all others: regular patient-doctor consultation and intensive, individualized patient education. Not new technology. Not more complex drug regimens. Conversation and follow-through.

The quality of your relationship with your patient is a clinical tool. It belongs in your toolkit right alongside every other evidence-based intervention you use.

Factor 3: Health Literacy — The Barrier We Keep Underestimating

Higher education and better health literacy are positively correlated with improved medication adherence. This makes intuitive sense. When patients understand their condition, they are more likely to understand why consistent treatment matters.

But the data on what low health literacy actually looks like in practice is sobering.

In a study of coronary artery disease patients in Peshawar, 74% of the patient population was illiterate. Lack of disease awareness appeared to influence adherence trends throughout the study. The adherence breakdown looked like this: 40.2% demonstrated great adherence, 41.1% showed moderate adherence, 15% showed very poor adherence, and 3.7% showed no compliance at all.

That is nearly 1 in 5 patients in that population either barely adhering or not adhering at all.

Here is the provider takeaway: education is not a pamphlet. It is a process. One that must be tailored to the individual, repeated across visits, and verified — not assumed. Handing a patient a printed sheet on their way out the door is not patient education. It is a checkbox.

Real education looks like asking your patient to explain the plan back to you. It looks like checking in at the next visit. It looks like adjusting your language to meet the patient where they are — not where you wish they were.

Factor 4: Side Effects and Treatment Complexity — The Dropout Triggers You Can Predict

This one is predictable. And because it is predictable, it is preventable.

Concern over potential side effects is a primary barrier to medication adherence identified across multiple studies. In asthma patients in Saudi Arabia, 20.4% stopped their medication specifically because of side effects. Another 36.9% stopped when they simply felt better — a phenomenon sometimes called “feeling-better dropout.”

Let that second number sink in. More than a third of non-adherent asthma patients in that study stopped their medication not because it was not working — but because it was working too well. They felt better and assumed the medication was no longer necessary.

This is a conversation that needs to happen before the patient walks out the door. Not after they stop their meds and come back three months later with a flare-up.

Treatment complexity compounds the problem further. Patients prescribed high doses or multiple drug combinations experience something researchers call treatment fatigue. The more complicated the regimen, the harder it is to stay consistent. This is not weakness. It is human nature.

Overall, only 39.3% of asthma patients in the Saudi Arabia study were adherent. 60.7% were not. Side effects and treatment complexity were significant contributors to that gap.

Anticipating these barriers before they become dropout events is one of the most practical adherence strategies available to any provider.

Factor 5: Demographics — The Inconsistent Variable (And Why That Is Actually the Point)

Demographic data tells a nuanced story. And providers should resist the urge to over-generalize from it.

In the Saudi Arabia asthma study, female gender, higher income, being married, and urban residence were all significantly associated with higher medication adherence. On the surface, that sounds like a clear pattern.

But in the Peshawar coronary artery disease study, no statistically significant association was found between adherence and gender, economic status, or cost of drugs. The pattern disappeared entirely.

What does that tell us? It tells us that condition-specific and population-specific factors appear to matter more than universal demographic patterns. Demographics can inform your thinking. They should never dictate your clinical assumptions.

Stop profiling. Start assessing.

Every patient in front of you is an individual with their own combination of barriers, habits, fears, and motivations. The research gives us categories to work from. Your conversation with the patient gives you the real picture.

The Provider Playbook: What the Research Actually Recommends

Here is a synthesis of what the evidence consistently points toward when it comes to improving medication adherence:

• Establish and protect the therapeutic relationship. Trust is a clinical variable. Invest in it deliberately, not incidentally.
• Prioritize patient motivation assessment. If an odds ratio of 26.488 does not convince you to start measuring motivation, nothing